Thymosin Alpha-1
Typical Dosage
Injection: 1.6 mg twice weekly
Administration
Injection
Half-Life
~2 hours
Mechanism of Action
Antiviral and immunomodulation research|Vaccine adjuvant studies|Oncology adjunct research|T-cell activation
Research Protocol Summary
Evidence Level
Human Clinical / Marketed
Typical Protocol Duration
Varies By Research Protocol
Species Studied
Human • Mouse • Rat
Administration Schedule
Once Weekly
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…